Retrospective Cohort Study Comparing Infliximab|dyyb and ...

Retrospective Cohort Study Comparing Infliximab-dyyb and ... - NCBI

To assess the effectiveness and safety of a biosimilar (infliximab-dyyb) and its reference product (infliximab) in patients with inflammatory bowel disease ( ...

Retrospective Cohort Study Comparing Infliximab-dyyb ... - PubMed

Results: The composite effectiveness outcome occurred in 107 of 870 patients (12.3%) in the infliximab-dyyb and 379 of 2336 patients (16.2%) in ...

Retrospective Cohort Study Comparing Infliximab-dyyb and ...

Initiation of infliximab-dyyb was non-inferior to infliximab among biologic-naive patients with IBD in an US integrated healthcare delivery system.

(PDF) Retrospective Cohort Study Comparing Infliximab-dyyb and ...

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United ...

[PDF] Retrospective Cohort Study Comparing Infliximab-dyyb and ...

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States · 2 Citations.

Persistence of subcutaneous versus intravenous infliximab in a real ...

Discussion. In this real-life retrospective cohort study, we compared IBD patients in remission switched to subcutaneous infliximab with ...

Retrospective Cohort Study Comparing Infliximab-dyyb ... - EBSCO

Title. Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States.

P58 A retrospective cohort study to compare subcutaneous ... - Gut

Introduction Phase III clinical trials have established the efficacy and safety of subcutaneous (SC) infliximab (IFX) in inflammatory bowel disease (IBD).

Does long-term efficacy differ between infliximab and adalimumab ...

A STROBE-compliant retrospective cohort study. Otake, Haruka MD; Matsumoto, Satohiro MD, PhD *; Mashima, Hirosato MD, PhD. Editor(s): ...

A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort ...

Comparing patients in the infliximab-dyyb group to a matched group of patients with IBD who remained on RP infliximab, the study demonstrated ...

Comparative effectiveness and drug survival of biosimilar infliximab ...

reference infliximab in inflammatory bowel disease: A retrospective cohort study ... However, there are limited cohort studies comparing the effectiveness ...

A 'real‐world' retrospective multi‐centre cohort study comparing ...

Patients with UC administered infliximab or adalimumab as their first biologic, identified from the therapy databases of five UK hospitals, were ...

A RETROSPECTIVE COHORT STUDY TO COMPARE THE ...

A retrospective cohort study to compare the efficacy, pharmacokinetics and safety of subcutaneous (SC) and intravenous (IV) infliximab in the treatment of ...

P58 A retrospective cohort study to compare subcutaneous with ...

Introduction Phase III clinical trials have established the efficacy and safety of subcutaneous (SC) infliximab (IFX) in inflammatory bowel ...

Long-term effectiveness and safety of infliximab-biosimilar - PLOS

Research Article. Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study. Tomoe Kazama ...

P782 Comparison of accelerated and standard infliximab induction ...

This retrospective multicenter study aimed to compare accelerated and standard infliximab induction in a Chinese cohort of ASUC patients, and to explore risk ...

Comparison of Infliximab and Adalimumab in Biologic-Naive ...

In contrast, observational comparative effectiveness studies using ... In another retrospective multisite cohort study in which 170 ...

Vedolizumab is superior to infliximab in biologic naïve patients with ...

We conducted a retrospective, real world, single-center study with a 52-week follow-up (FU), to compare the efficacy of IFX and VDZ in two ...

Infliximab vs Adalimumab for UC: Is There A Difference?

present the results of their retrospective cohort study comparing the effectiveness and safety of infliximab and adalimumab for the ...

Comparative real-world outcomes between ustekinumab, infliximab ...

... compare the efficacy and clinical outcomes between UST, IFX, and ADA. Methods. Patients. This retrospective cohort study was conducted at ...